[HTML][HTML] Association of multiple preventive therapies postdischarge and long-term health outcomes after acute myocardial infarction
CW Chen, YC Lin, CM Shih, WT Chen… - Journal of the …, 2021 - journals.lww.com
Background: Statins, beta-blockers, and angiotensin-converting enzyme
inhibitors/angiotensin II receptor blockers have been advocated by guidelines as secondary …
inhibitors/angiotensin II receptor blockers have been advocated by guidelines as secondary …
Association of multiple preventive therapies postdischarge and long-term health outcomes after acute myocardial infarction
CW Chen, YC Lin, CM Shih, WT Chen… - Journal of the …, 2021 - hub.tmu.edu.tw
BACKGROUND: Statins, beta-blockers, and angiotensin-converting enzyme
inhibitors/angiotensin II receptor blockers have been advocated by guidelines as secondary …
inhibitors/angiotensin II receptor blockers have been advocated by guidelines as secondary …
Association of multiple preventive therapies postdischarge and long-term health outcomes after acute myocardial infarction
CW Chen, YC Lin, CM Shih… - Journal of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Statins, beta-blockers, and angiotensin-converting enzyme
inhibitors/angiotensin II receptor blockers have been advocated by guidelines as secondary …
inhibitors/angiotensin II receptor blockers have been advocated by guidelines as secondary …
Association of multiple preventive therapies postdischarge and long-term health outcomes after acute myocardial infarction
CW Chen, YC Lin, CM Shih, WT Chen… - Journal of the …, 2021 - scholar.nycu.edu.tw
BACKGROUND: Statins, beta-blockers, and angiotensin-converting enzyme
inhibitors/angiotensin II receptor blockers have been advocated by guidelines as secondary …
inhibitors/angiotensin II receptor blockers have been advocated by guidelines as secondary …
Association of multiple preventive therapies postdischarge and long-term health outcomes after acute myocardial infarction.
CW Chen, YC Lin, CM Shih, WT Chen… - Journal of the …, 2021 - europepmc.org
Background Statins, beta-blockers, and angiotensin-converting enzyme
inhibitors/angiotensin II receptor blockers have been advocated by guidelines as secondary …
inhibitors/angiotensin II receptor blockers have been advocated by guidelines as secondary …
Association of multiple preventive therapies postdischarge and long-term health outcomes after acute myocardial infarction
CW Chen, YC Lin, CM Shih, WT Chen… - Journal of the …, 2021 - hub.tmu.edu.tw
BACKGROUND: Statins, beta-blockers, and angiotensin-converting enzyme
inhibitors/angiotensin II receptor blockers have been advocated by guidelines as secondary …
inhibitors/angiotensin II receptor blockers have been advocated by guidelines as secondary …